Latest News
-
Antibody blocks infection of SARS-CoV-2 in cultured cells
Scientists have identified a fully human monoclonal antibody that prevents the SARS-CoV-2 virus from infecting cultured cells, it was announced last night. Read more
-
Men and women’s same three heart symptoms
The top three acute coronary symptoms are the same in both women and men, according to a new Dutch study published last night. Read more
-
Immune system clues to virus care
Immune suppressants might play a role in the early treatment of Covid-19, one expert has suggested amid several studies highlighting the body’s over-reaction to the virus. Read more
-
Anti-Ebola drug and antibody show promise
The anti-Ebola drug remdesivir has shown major promise in a global clinical trial involved Covid-19 patients, it was announced last night. Read more
-
Preterm delivery risk following first pregnancy complications
Women who experience complications in their first pregnancy but deliver at full term are at increased risk of preterm delivery in their next pregnancy, according to a new Norwegian study. Read more
-
Hope for Covid-19 inflammation therapy
Scientists are working on a new nanoparticle treatment for septic shock and uncontrolled inflammation that might help Covid-19 care. Read more
-
Hope for non-chemo prostate cancer drug
The breast and ovarian cancer drug olaparib may also be effective against prostate cancer. Read more
-
Gut neurons linked to Parkinson’s disease
Researchers have investigated which types of nerve cells contain genes linked to Parkinson’s disease, pinpointing a cluster in the gut. Read more
-
Gene defects linked to babies’ eczema, wheeze and nasal disease
A link between a common gene defect and eczema, nasal blockage and wheeze among babies as young as six months has been identified, a new study has revealed. Read more
-
Blood plasma collection stepped up in therapy hope
Up to 10,000 units of blood plasma a week could be collected in the UK if it proves a successful therapy for the Covid-19 virus, it has been announced. Read more